Statins for primary prevention in practice: clinical use in Wales and the NICE guideline effect

Br J Clin Pharmacol. 2016 Sep;82(3):892-4. doi: 10.1111/bcp.13014. Epub 2016 Jun 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cardiovascular Diseases / prevention & control
  • Drug Costs
  • Guideline Adherence
  • Guidelines as Topic
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / economics
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Primary Prevention* / economics
  • Wales

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors